Better medication management for WTC responders
This study helps WTC responders aged 50+ who take certain common medications learn how to manage them better and stay healthy as they age. You must already be enrolled in Mount Sinai's aging study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a World Trade Center responder who is already part of the Mount Sinai aging study.
- You are 50 years or older.
- You are currently taking at least one of these medicines: PPIs (acid reflux meds), benzodiazepines (anti-anxiety), Z-drugs (sleep aids), first-generation antihistamines (old allergy meds like Benadryl), or skeletal muscle relaxants.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to reduce the number of long-term medicines older adults take when they have multiple chronic conditions. It may help by simplifying medicine routines and improving safety and care coordination with a family doctor.
This study looks at older adults who take multiple medicines to understand why some have side effects. By joining, you help researchers learn how to make medicines safer for people your age.
This study tests if a pre-visit questionnaire helps older adults and their doctors talk about certain medications. You may be asked about taking a statin for heart health or stopping a high-risk medication.
This study tests a patient-centered plan to safely reduce certain medicines that may cause side effects in older people who take many drugs. It aims to improve safety and comfort by lowering unnecessary use while keeping you well.
This study will see if working closely with your doctor and pharmacist can help older adults safely reduce or stop taking medications for anxiety or sleep, like benzodiazepines.
This study looks at what older patients think about stopping or reducing tranquilizers and sleep medications. It is a survey-based study that helps hospitals improve how they support patients with this medication.
Hear when a new Polypharmacy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.